Ani Pharmaceuticals reported $73.85M in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 14583M 1045M
Aerie Pharmaceuticals AERI:US $ 33.31M 3.48M
Ani Pharmaceuticals ANIP:US $ 73.86M 9.38M
Aurora Cannabis Inc ACB:CN 50.43M 10.15M
Canopy Growth Corp WEED:CN C$ 110.12M 1.66M
Depomed DEPO:US $ 35.13M 1.41M
Eli Lilly And LLY:US $ 6488M 1322M
Emergent Biosolutions EBS:US $ 242.7M 64.8M
Heron Therapeutics HRTX:US $ 27.63M 4.17M
Hikma Pharmaceutical HIK:LN 1.21B 124M
Knight Therapeutics Inc GUD:CN C$ 63.81M 5.53M
Lannett LCI:US $ 78.36M 8.15M
Nektar Therapeutics NKTR:US $ 21.58M 3.24M
Novartis NVS:US $ 13085M 271M
Perrigo Ordinary Shares PRGO:US $ 1121.7M 47.2M
Sun Pharmaceuticals SUNP:IN IR 107617.6M 13150M
Teva Pharmaceutical TEVA:IT 3.79B 125M
Teva Pharmaceutical Industries TEVA:US $ 3786M 125M